The increase in incidence of autoimmune & respiratory conditions, comprehensive pipeline of drug development, and rise in prominence of anti-inflammatory drugs having lesser side effects are the factors that drive the global anti-inflammatory therapeutics market growth.
According to a report published by Allied Market Research, the global anti-inflammatory therapeutics market is estimated to generate $106.1 billion by 2020, growing at a CAGR of 5.9% from 2015 to 2020. The anti-inflammatory biologics segment accounted for nearly three-fifths of total market share in 2014. The Asia-Pacific region is expected to portray the largest CAGR of 8.5% during the forecast period.
The increase in incidence of autoimmune & respiratory conditions, comprehensive pipeline of drug development, and rise in prominence of anti-inflammatory drugs having lesser side effects are the factors that drive the global anti-inflammatory therapeutics market growth. Moreover, increase in awareness regarding anti-inflammatory therapeutics and government initiatives in Asia-Pacific and LAMEA supplement the market growth. However, adverse effects related to long term consumption of drugs such as NSAIDs and Corticosteroids are expected to hinder the market growth.
Download Sample Copy of this Report @ https://www.alliedmarketresearch.com/request-sample/286
The anti-inflammatory biologics held the highest market share in 2014 and is expected to experience the highest growth rate throughout the forecast period. This is due to the emergence of targeted anti-inflammatory biosimilars and biologics with low number of side effects. Among indication segment, arthritis would continue its lead position by 2020, owing to high incidence rate and preference for anti-inflammatory biologics for treating arthritis.
Key findings of the report:
- Arthritis indication contributed the highest revenue in the global anti-inflammatory therapeutics market in 2014, followed by respiratory diseases.
- Psoriasis segment is expected to register a CAGR of 8.1%, the highest among all other segment.
- North America is expected to maintain its lead in the market by 2020.
- The U.S. held nearly five-sixth of the total revenue of the North America anti-inflammatory therapeutics market.
- Asia-Pacific is expected to become the highest growing segment.
In developed countries including North America and Europe, branded drugs have been preferred over generics, however, a reverse trend in developing economies has taken place. This is due to presence of nearly half of the anti-inflammatory biologics market in the North America, however, Asia Pacific and LAMEA collectively contributed for more than one-third of the total share in NSAIDs market as compared to nearly 25% share of the branded biologics market in 2014.
Companies have adopted drug pipeline development and new product launch as major strategies for tackling patent expiries of existing drugs and acquire additional market share. Key companies analyzed in the research include Pfizer Inc., Johnson & Johnson, Abbvie Inc., Merck & Co., Inc. GlaxoSmithKline, F. Hoffman La Roche AG, Novartis, AstraZeneca PLC, Eli Lily and Company, and Amgen.
Check available discounts on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/286
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.